Current pipelines for neglected diseases.

by Paolo di Procolo, Claudio Jommi
Published 2014-09-01

Title not available

by Sanja Stanisic, Antonio Bertolotto, Patrizia Berto, Paolo Di Procolo, Julia Morawski
Published 2019-04-01

Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

by Giovanni Gancitano, Roberto Ravasio, Lorenzo Cattelino, Paolo Di Procolo, Diego Cortinovis
Published 2020-02-01

The cost-effectiveness of alemtuzumab in the management of relapse-remitting multiple sclerosis in Italy

by Sanja Stanisic, Antonio Bertolotto, Patrizia Berto, Paolo Di Procolo, Julia Morawski
Published 2019-04-01

Arginine-specific mono ADP-ribosylation in vitro of antimicrobial peptides by ADP-ribosylating toxins.

by Marta Castagnini, Monica Picchianti, Eleonora Talluri, Massimiliano Biagini, Mariangela Del Vecchio, Paolo Di Procolo, Nathalie Norais, Vincenzo Nardi-Dei, Enrico Balducci
Published 2012-01-01